The agency first approved Xeljanz to treat rheumatoid arthritis in 2012 and psoriatic arthritis in 2017. Now, physicians can also use the drug to treat adults with moderate-to-severe ulcerative colitis.
Xeljanz represents the first oral medication approved for this use. Other approved treatments for ulcerative colitis require administration via an intravenous infusion or subcutaneous injection.
More articles on supply chain:
How Amazon’s latest patent would let customers interact with delivery drones
Allergan recalls 170k birth control samples with placebo pills in wrong order
Fortune’s 5 most influential pharmaceutical distributors and PBMs
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
